ARTEMISBIO
LIVE

Serial Number

50119837

Owner

Artemis Therapeutics Limited

Attorney

Marlene J. Williams

Filing Date

Sep 21, 2026

Add to watchlist:

No watchlists yet
View on USPTO

ARTEMISBIO Trademark

Serial Number: 50119837

ARTEMISBIO is a trademark filed by Artemis Therapeutics Limited on September 21, 2026. The trademark is classified under Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Artemis Therapeutics Limited

5 New Street Square
London EC4A 3TW , GB

Entity Type: 99

Trademark Details

Filing Date

September 21, 2026

Registration Date

Not Registered

Goods & Services

Advertising and publicity; presentation of goods on communication media, for retail purposes; retail services for pharmaceutical, veterinary and sanitary preparations and medical supplies; marketing; providing business information via a web site; market studies; organization of exhibitions for commercial or advertising purposes; collection of data and management of data in connection with clinical research, testing, trial and development of pharmaceuticals, therapeutics and medical products and preparations; computerised database management and data processing services in the fields of medicines, pharmaceuticals and therapeutics; business management in the field of pharmaceuticals, therapeutics and medical products and preparations; business consultancy in the field of pharmaceuticals, therapeutics and medical products and preparations; assistance in business management; business consultancy and advisory services; business analysis, research and information services; promotion and representation of companies for preserving and developing the activities thereof

Scientific, technological, medical and pharmaceutical research and development services; advisory services relating to science; laboratory research and analysis services; clinical research; pharmaceutical drug development services; scientific investigations for medical purposes; scientific research relating to biology; scientific research relating to genetics; medical laboratory services; research and development of pharmaceutical preparations; scientific, medical and pharmaceutical research and development services in the field of oncology, immunology, and metabolic diseases; drug discovery services; research and development services in the fields of biotechnology, biochemicals and biological products; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical products development; research and development in the pharmaceutical and biotechnology fields; testing of pharmaceuticals; clinical studies related to pharmaceutical products; evaluation and inspection of pharmaceuticals; genetic testing for research purposes; research in the field of gene and cell therapy; design services for chemical products; design and development of computers and software; scientific consulting; design of computational models and systems of artificial intelligence; testing, authentication and quality control; software development, programming and implementation; providing a web-based software platform for laboratory and diagnostic equipment information management, monitoring and analysis; biomarker discovery services; providing a web-based software platform for data management, monitoring and analysis in the field of medical diagnostics; software as a service (SaaS) services in the field of medical diagnostics; hosting, managing, developing, and maintaining applications, software, and web sites related to medical diagnostics instruments and systems; computer services, including remote data management for medical diagnostic instruments, remote management of medical diagnostic systems and monitoring and reporting on the performance and errors of medical diagnostic instruments; providing an on-line network environment that features technology that enables users to share data in the field of medical diagnostics; providing temporary use of non-downloadable software and applications for monitoring medical diagnostic instruments and managing data from medical diagnostic instruments; evaluation and inspection of pharmaceuticals; advisory, consultancy and information services relating to all of the foregoing

Filing History

APPLICATION FILING RECEIPT MAILED
Sep 21, 2026 MAFR
NEW APPLICATION ENTERED
Sep 21, 2026 NWAP